An Extension Study of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus
Clinical trial NCT03407482 · TERMINATED
Trial details
- NCT number
- NCT03407482
- Sponsor
- Genentech, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-09
- Primary completion
- 2019-11-20
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.